論文

査読有り 国際誌
2020年2月19日

Proposal of a liver histology-based scoring system for bile salt export pump deficiency.

Hepatology research : the official journal of the Japan Society of Hepatology
  • Yoh Zen
  • Hiroki Kondou
  • Atsuko Nakazawa
  • Ken Tanikawa
  • Yasuhiro Hasegawa
  • Kazuhiko Bessho
  • Kazuo Imagawa
  • Takashi Ishige
  • Ayano Inui
  • Mitsuyoshi Suzuki
  • Mureo Kasahara
  • Kouji Yamamoto
  • Takako Yoshioka
  • Masayoshi Kage
  • Hisamitsu Hayashi
  • 全て表示

50
6
開始ページ
754
終了ページ
762
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1111/hepr.13494

AIM: Bile salt export pump (BSEP) deficiency manifests a form of progressive intrahepatic cholestasis. This study aimed to establish a scoring system of liver histology for the uncommon genetic condition. METHODS: After a roundtable discussion and a histology review, a scoring system for BSEP deficiency was established. Eleven tissue samples were independently evaluated by three pathologists based on the proposed standard for an interobserver agreement analysis. In four cases with serial tissue samples available, correlation between changes in histology scores and clinical outcome was examined. RESULTS: Of 14 initially listed histopathological findings, 12 were selected for scoring and grouped into the following four categories: cholestasis, parenchymal changes, portal tract changes, and fibrosis. Each category consisted of two to four microscopic findings that were further divided into three to six scores; therefore, each category had a maximum score of 8 to 11. Interobserver agreement was highest for pericellular fibrosis (κ value: 0.849) and lowest for hepatocellular cholestasis (κ value: 0.241) with the mean and median κ values of the 12 parameters being 0.561 and 0.602, respectively. For two patients whose clinical features worsened, score changes between two time points were interpreted as deteriorated. In two patients, who showed a good clinical response to preprandial treatment with sodium 4-phenylbutyrate, histological changes were evaluated as improved or unchanged. CONCLUSIONS: The proposed histology-based scoring system for BSEP deficiency with moderate interobserver agreement may be useful not only for monitoring microscopic changes in the clinical practice but also for a surrogate endpoint in clinical trials.

リンク情報
DOI
https://doi.org/10.1111/hepr.13494
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32073700
ID情報
  • DOI : 10.1111/hepr.13494
  • PubMed ID : 32073700

エクスポート
BibTeX RIS